Uncategorized

FDA hold puts Aardvark Prader-Willi drug in limbo

Published

on

The company plans to unblind the late-stage study that was halted due to safety concerns, which could lead to an overhaul of its entire development program.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version